Continuous glucose monitoring-derived time in range and CV are associated with altered tissue characteristics of the carotid artery wall in people with type 2 diabetes

被引:0
作者
Tomoya Mita
Naoto Katakami
Yosuke Okada
Hidenori Yoshii
Takeshi Osonoi
Keiko Nishida
Toshihiko Shiraiwa
Akira Kurozumi
Naohiro Taya
Satomi Wakasugi
Fumiya Sato
Ryota Ishii
Masahiko Gosho
Iichiro Shimomura
Hirotaka Watada
机构
[1] Juntendo University Graduate School of Medicine,Department of Metabolism & Endocrinology
[2] Osaka University Graduate School of Medicine,Department of Metabolic Medicine
[3] University of Occupational and Environmental Health,First Department of Internal Medicine, School of Medicine
[4] Juntendo Tokyo Koto Geriatric Medical Center,Department of Medicine, Diabetology & Endocrinology
[5] Nakakinen Clinic,Department of Biostatistics, Faculty of Medicine
[6] Nishida Keiko Diabetes Clinic,undefined
[7] Shiraiwa Medical Clinic,undefined
[8] University of Tsukuba,undefined
来源
Diabetologia | 2023年 / 66卷
关键词
Atherosclerosis; Continuous glucose monitoring; Glucose variability; Grey-scale median; Intima–media thickness;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2356 / 2367
页数:11
相关论文
共 154 条
[1]  
Rawshani A(2017)Mortality and cardiovascular disease in type 1 and type 2 diabetes N Engl J Med 376 1407-1418
[2]  
Rawshani A(2013)Vascular complications of diabetes: mechanisms of injury and protective factors Cell Metab 17 20-33
[3]  
Franzen S(2020)Japanese clinical practice guideline for diabetes 2019 Diabetol Int 11 1020-1076
[4]  
Rask-Madsen C(2018)Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia 61 2461-2498
[5]  
King GL(1998)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837-853
[6]  
Araki E(2022)Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia 65 1925-1966
[7]  
Goto A(2023)6. Glycemic targets: standards of care in diabetes-2023 Diabetes Care 46 S97-S110
[8]  
Kondo T(2000)Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 405-412
[9]  
Davies MJ(1995)The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial Diabetes 44 968-983
[10]  
D’Alessio DA(2008)Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2545-2559